- Home
- BCDA vs LXEH Comparison
BCDA vs LXEH Comparison
Compare BCDA & LXEH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCDA
- LXEH
- Stock Information
- Founded
- BCDA N/A
- LXEH 2001
- Country
- BCDA United States
- LXEH China
- Employees
- BCDA N/A
- LXEH N/A
- Industry
- BCDA Biotechnology: Pharmaceutical Preparations
- LXEH Other Consumer Services
- Sector
- BCDA Health Care
- LXEH Real Estate
- Exchange
- BCDA Nasdaq
- LXEH Nasdaq
- Market Cap
- BCDA 11.3M
- LXEH 12.5M
- IPO Year
- BCDA N/A
- LXEH 2020
- Fundamental
- Price
- BCDA $1.39
- LXEH $0.56
- Analyst Decision
- BCDA Strong Buy
- LXEH
- Analyst Count
- BCDA 1
- LXEH 0
- Target Price
- BCDA $25.00
- LXEH N/A
- AVG Volume (30 Days)
- BCDA 306.5K
- LXEH 2.9M
- Earning Date
- BCDA 11-12-2025
- LXEH 09-26-2025
- Dividend Yield
- BCDA N/A
- LXEH N/A
- EPS Growth
- BCDA N/A
- LXEH N/A
- EPS
- BCDA N/A
- LXEH N/A
- Revenue
- BCDA N/A
- LXEH $4,585,942.00
- Revenue This Year
- BCDA N/A
- LXEH N/A
- Revenue Next Year
- BCDA N/A
- LXEH N/A
- P/E Ratio
- BCDA N/A
- LXEH N/A
- Revenue Growth
- BCDA N/A
- LXEH N/A
- 52 Week Low
- BCDA $1.00
- LXEH $0.31
- 52 Week High
- BCDA $3.20
- LXEH $50.08
- Technical
- Relative Strength Index (RSI)
- BCDA 42.69
- LXEH 30.41
- Support Level
- BCDA $1.40
- LXEH $0.31
- Resistance Level
- BCDA $1.52
- LXEH $0.38
- Average True Range (ATR)
- BCDA 0.11
- LXEH 0.27
- MACD
- BCDA 0.02
- LXEH -0.05
- Stochastic Oscillator
- BCDA 32.82
- LXEH 10.22
About BCDA BioCardia Inc.
BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).
About LXEH Lixiang Education Holding Co. Ltd.
Lixiang Education Holding Co Ltd is a private primary and secondary education service provider in Lishui City, Zhejiang Province. Its private education services primarily include primary and middle school education from grade 1 to grade 9. The company also offers high school education services at its High School Divisions.